Surgical results of thyroid nodules according to a management guideline based on the BRAFV600E mutation status

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 3, 2011, Pages 658-664

  Kim, Suk Kyeong ^a   Hwang, Tae Sook ^b   Yoo, Young Bum ^a   Han, Hye Seung ^b   Kim, Dong Lim ^a   Song, Kee Ho ^a   Lim, So Duk ^b   Kim, Wan Seop ^b   Paik, Nam Sun ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE;

ADULT; ARTICLE; ASPIRATION BIOPSY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLICULAR ADENOMA; FOLLICULAR CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NODULAR HYPERPLASIA; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYROSEQUENCING; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; TREATMENT INDICATION;

BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; GUIDELINES AS TOPIC; HUMANS; MUTATION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS B-RAF; REPUBLIC OF KOREA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NODULE;

EID: 79952309163     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1082     Document Type: Article

References (20)

1. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S 2003 Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88:4393-4397 (Pubitemid 37153748)
2. Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M 2005 Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch 446:589-595 (Pubitemid 40922263)
3. Ezzat S, Sarti DA, Cain DR, Braunstein GD 1994 Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838-1840
4. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore Jr FD, Larsen PR, Marqusee E, Alexander EK 2006 Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 91:3411-3417 (Pubitemid 44402112)
5. Kang HW, No JH, Chung JH, Min YK, Lee MS, Lee MK, Yang JH, Kim KW 2004 Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. Thyroid 14:29-33 (Pubitemid 38282934)
6. Kim DL, Song KH, Kim SK 2008 High prevalence of carcinoma in ultrasonography-guided fine needle aspiration cytology of thyroid nodules. Endocr J 55:135-142 (Pubitemid 351520190)
7. Lee HK, Hur MH, Ahn SM 2003 Diagnosis of occult thyroid carcinoma by ultrasonography. Yonsei Med J 44:1040-1044 (Pubitemid 38081572)
8. Kim N, Lavertu P 2003 Evaluation of a thyroid nodule. Otolaryngol Clin North Am 36:17-33 (Pubitemid 36384138)
9. Baloch ZW, Sack MJ, Yu GH, Livolsi VA, Gupta PK 1998 Fine-needle aspiration of thyroid: an institutional experience. Thyroid 8:565-569 (Pubitemid 28354907)
10. Xing M 2005 BRAF mutation in thyroid cancer. Endocrine Related Cancer 12:245-262 (Pubitemid 40896444)
11. Kim KH, Kang DW, Kim SH, Seong IO, Kang DY 2004 Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 45:818-821 (Pubitemid 39545368)
12. Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G, Lee S, Kim SY, Kim SC, Hong SJ, Shong YK 2006 The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol (Oxf) 65:364-368
13. Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park do J, Lee HS, Cho BY, Lee ES, Kim SW 2006 Detection of BRAF600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf) 65:660-666 (Pubitemid 44583829)
14. Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, Oh SY, Hwang TS 2008 Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 17:118-125
15. Kim SK, Song KH, Lim SD, Lim YC, Yoo YB, Kim JS, Hwang TS 2009 Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 19:137-141
16. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ 2008 Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425-437 (Pubitemid 351829800)
17. Koh CS, Ku JL, Park SY, Kim KH, Choi JS, Kim IJ, Park JH, Oh SK, Chung JK, Lee JH, Kim WH, Kim CW, Cho BY, Park JG 2007 Establishment and characterization of cell lines from three human thyroid carcinomas: Responses to all-trans-retinoic acid and mutations in the BRAF gene. Mol Cell Endocrinol 264:118-127
18. Nikiforova MN, Nikiforov YE 2009 Molecular diagnostic and predictors in thyroid cancer. Thyroid 19:1351-1361
19. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404 (Pubitemid 37452745)
20. Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA 2003 High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res 63:4561-4567 (Pubitemid 36951030)